Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Pancreatic Ductal Adenocarcinoma × sonidegib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Ductal Adenocarcinoma 1 Carcinoma, Basal Cell 1

Interventions

sonidegib 1 glucoraphanin 1 Transurethral Resection of Prostate 1 Tissue Banks 1 Specimen Handling 1 Saline Solution 1 Ropivacaine 1 Robotic Surgical Procedures 1 Pancreaticoduodenectomy 1 Glucose 1 Genetic Testing 1 Electroporation 1 Drug Therapy 1 Conversion to Open Surgery 1 Contrast Media 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01911416 2016-06-09

A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer

University of Utah

Phase NA Withdrawn

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡